0010 - Statement - Consolidated Statement of Earnings link:presentationLink link:calculationLink link:definitionLink 0020 - Statement - Consolidated Statement of Cash Flows link:presentationLink link:calculationLink link:definitionLink 0030 - Statement - Consolidated Balance Sheet link:presentationLink link:calculationLink link:definitionLink 0035 - Statement - Consolidated Balance Sheet (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 9999 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 8000 - Disclosure - Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 1020 - Disclosure - Supplemental Financial Information link:presentationLink link:calculationLink link:definitionLink 1050 - Disclosure - Taxes on Earnings link:presentationLink link:calculationLink link:definitionLink 1070 - Disclosure - Litigation and Environmental Matters link:presentationLink link:calculationLink link:definitionLink 1040 - Disclosure - Post-Employment Benefits link:presentationLink link:calculationLink link:definitionLink 8050 - Disclosure - Comprehensive Income, net of tax link:presentationLink link:calculationLink link:definitionLink 8030 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 1080 - Disclosure - Incentive Stock Program link:presentationLink link:calculationLink link:definitionLink 8020 - Disclosure - Conclusion of TAP Pharmaceutical Products Inc. Joint Venture link:presentationLink link:calculationLink link:definitionLink 1100 - Disclosure - Business Combinations, Technology Acquisitions and Related Transactions link:presentationLink link:calculationLink link:definitionLink 1030 - Disclosure - Financial Instruments, Derivatives and Fair Value Measures link:presentationLink link:calculationLink link:definitionLink 1120 - Disclosure - Goodwill and Intangible Assets link:presentationLink link:calculationLink link:definitionLink 1130 - Disclosure - Restructuring Plans link:presentationLink link:calculationLink link:definitionLink 8010 - Disclosure - Subsequent Event - Litigation Settlement link:presentationLink link:calculationLink link:definitionLink 3020 - Disclosure - Supplemental Financial Information (Tables) link:presentationLink link:calculationLink link:definitionLink 4021 - Disclosure - Supplemental Financial Information (Details 2) link:presentationLink link:calculationLink link:definitionLink 4020 - Disclosure - Supplemental Financial Information (Details) link:presentationLink link:calculationLink link:definitionLink 4022 - Disclosure - Supplemental Financial Information (Details 3) link:presentationLink link:calculationLink link:definitionLink 8040 - Disclosure - Conclusion of TAP Pharmaceutical Products Inc. Joint Venture (Tables) link:presentationLink link:calculationLink link:definitionLink 8060 - Disclosure - Conclusion of TAP Pharmaceutical Products Inc. Joint Venture (Details) link:presentationLink link:calculationLink link:definitionLink 4050 - Disclosure - Taxes on Earnings (Details) link:presentationLink link:calculationLink link:definitionLink 3040 - Disclosure - Post-Employment Benefits (Tables) link:presentationLink link:calculationLink link:definitionLink 4040 - Disclosure - Post-Employment Benefits (Details) link:presentationLink link:calculationLink link:definitionLink 4070 - Disclosure - Litigation and Environmental Matters (Details) link:presentationLink link:calculationLink link:definitionLink 8080 - Disclosure - Comprehensive Income, net of tax (Details) link:presentationLink link:calculationLink link:definitionLink 8070 - Disclosure - Comprehensive Income, net of tax (Tables) link:presentationLink link:calculationLink link:definitionLink 3060 - Disclosure - Segment and Geographic Area Information (Tables) link:presentationLink link:calculationLink link:definitionLink 4060 - Disclosure - Segment and Geographic Area Information (Details) link:presentationLink link:calculationLink link:definitionLink 3080 - Disclosure - Incentive Stock Program (Tables) link:presentationLink link:calculationLink link:definitionLink 4080 - Disclosure - Incentive Stock Programs (Details) link:presentationLink link:calculationLink link:definitionLink 3030 - Disclosure - Financial Instruments, Derivatives and Fair Value Measures (Tables) link:presentationLink link:calculationLink link:definitionLink 4030 - Disclosure - Financial Instruments, Derivatives and Fair Value Measures (Details) link:presentationLink link:calculationLink link:definitionLink 4031 - Disclosure - Financial Instruments, Derivatives and Fair Value Measures (Details 2) link:presentationLink link:calculationLink link:definitionLink 4032 - Disclosure - Financial Instruments, Derivatives and Fair Value Measures (Details 3) link:presentationLink link:calculationLink link:definitionLink 4120 - Disclosure - Goodwill and Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 3130 - Disclosure - Restructuring Plans (Tables) link:presentationLink link:calculationLink link:definitionLink 4130 - Disclosure - Restructuring Plans (Details) link:presentationLink link:calculationLink link:definitionLink 3100 - Disclosure - Business Combinations, Technology Acquisitions and Related Transactions (Tables) link:presentationLink link:calculationLink link:definitionLink 4100 - Disclosure - Business Combinations, Technology Acquisitions and Related Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 4121 - Disclosure - Goodwill and Intangible Assets (Details 2) link:presentationLink link:calculationLink link:definitionLink 0040 - Statement - Consolidated Statement of Shareholders' Investment link:presentationLink link:calculationLink link:definitionLink 1010 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 1090 - Disclosure - Debt and Lines of Credit link:presentationLink link:calculationLink link:definitionLink 1110 - Disclosure - Conclusion of TAP Pharmaceutical Products Inc. Joint Venture and Sale of Abbott's Spine Business link:presentationLink link:calculationLink link:definitionLink 1150 - Disclosure - Quarterly Results (Unaudited) link:presentationLink link:calculationLink link:definitionLink 1060 - Disclosure - Segment and Geographic Area Information link:presentationLink link:calculationLink link:definitionLink 0045 - Statement - Consolidated Statement of Shareholders' Investment (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 4150 - Disclosure - Quarterly Results (Unaudited) (Details) link:presentationLink link:calculationLink link:definitionLink 3150 - Disclosure - Quarterly Results (Unaudited) (Tables) link:presentationLink link:calculationLink link:definitionLink 3090 - Disclosure - Debt and Lines of Credit (Tables) link:presentationLink link:calculationLink link:definitionLink 4090 - Disclosure - Debt and Lines of Credit (Details) link:presentationLink link:calculationLink link:definitionLink 4041 - Disclosure - Post-Employment Benefits (Details 2) link:presentationLink link:calculationLink link:definitionLink 2010 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 3010 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 4010 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 4110 - Disclosure - Conclusion of TAP Pharmaceutical Products Inc. Joint Venture and Sale of Abbott's Spine Business (Details) link:presentationLink link:calculationLink link:definitionLink 4051 - Disclosure - Taxes on Earnings (Details 2) link:presentationLink link:calculationLink link:definitionLink 3050 - Disclosure - Taxes on Earnings (Tables) link:presentationLink link:calculationLink link:definitionLink 4061 - Disclosure - Segment and Geographic Area Information (Details 2) link:presentationLink link:calculationLink link:definitionLink 4062 - Disclosure - Segment and Geographic Area Information (Details 3) link:presentationLink link:calculationLink link:definitionLink 1140 - Disclosure - Subsequent Event link:presentationLink link:calculationLink link:definitionLink 4140 - Disclosure - Subsequent Event (Details) link:presentationLink link:calculationLink link:definitionLink 1300 - Disclosure - Schedule II Valuation and Qualifying Accounts link:presentationLink link:calculationLink link:definitionLink 3300 - Disclosure - Schedule II Valuation and Qualifying Accounts (Table) link:presentationLink link:calculationLink link:definitionLink 4300 - Disclosure - Schedule II Valuation and Qualifying Accounts (Details) link:presentationLink link:calculationLink link:definitionLink 1301 - Disclosure - Schedule II Valuation and Qualifying Accounts (Parenthetical) link:presentationLink link:calculationLink link:definitionLink